Clinical Trials Logo

Spermatic Cord Block clinical trials

View clinical trials related to Spermatic Cord Block.

Filter by:
  • None
  • Page 1

NCT ID: NCT06313775 Enrolling by invitation - Prostate Cancer Clinical Trials

Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications between SA and SCB groups in metastatic prostate cancer patient. The main question it aims to answer are: • Is there a difference in the level of pain during bilateral orchiectomy between spinal anesthesia and spermatic cord block? Participants will undergo bilateral orchidectomy. They will be randomly assigned to two groups: the group receiving spinal anesthesia and the group receiving spermatic cord block If there is a comparison group: Researchers will compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications in both groups of patients.

NCT ID: NCT04498351 Completed - Clinical trials for Spermatic Cord Block

Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine

Start date: June 30, 2020
Phase: Early Phase 1
Study type: Interventional

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium.

NCT ID: NCT04492319 Completed - Clinical trials for Spermatic Cord Block

Addition of Neostigmine to Levobupivacaine

Start date: September 29, 2020
Phase: N/A
Study type: Interventional

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as neostigmine.